Ubiquitin dimers control the hydrolase activity of UCH-L3

Neurochemistry International

Volumn 54, Issue 5-6, 2009, Pages 314-321

  Setsuie, Rieko ^a   Sakurai, Mikako ^a   Sakaguchi, Yuriko ^b   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ubiquitin; Ubiquitin carboxy terminal hydrolase L1 (UCH L1); Ubiquitin carboxy terminal hydrolase L3 (UCH L3); Ubiquitin dimer

Indexed keywords

DIMER; UBIQUITIN; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; BRAIN; CELL LINE, TRANSFORMED; CYSTEINE ENDOPEPTIDASES; DIMERIZATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; HYDROLASES; MICE; MICE, TRANSGENIC; UBIQUITIN; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

MUS;

EID: 61449129071     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.12.013     Document Type: Article

References (43)

1. Das C., Hoang Q.Q., Kreinbring C.A., Luchansky S.J., Meray R.K., Ray S.S., Lansbury P.T., Ringe D., and Petsko G.A. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4675-4680
2. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
3. Harada T., Harada C., Wang Y.L., Osaka H., Amanai K., Tanaka K., Takizawa S., Setsuie R., Sakurai M., Sato Y., Noda M., and Wada K. Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo. Am. J. Pathol. 164 (2004) 59-64
4. Hegde A., and Upadhya S. The ubiquitin-proteasome pathway in health and disease of the nervous system. Trends Neurosci. 30 (2007) 587-595
5. Hemelaar J., Borodovsky A., Kessler B.M., Reverter D., Cook J., Kolli N., Gan-Erdene T., Wilkinson K.D., Gill G., Lima C.D., Ploegh H.L., and Ovaa H. Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins. Mol. Cell Biol. 24 (2004) 84-95
6. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
7. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2 (2001) 195-201
8. Hochstrasser M. Lingering mysteries of ubiquitin-chain assembly. Cell 124 (2006) 27-34
9. Johnston S.C., Larsen C.N., Cook W.J., Wilkinson K.D., and Hill C.P. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1,8 A resolution. Embo J. 16 (1997) 3787-3796
10. Kabuta T., Setsuie R., Mitsui T., Kinugawa A., Sakurai M., Aoki S., Uchida K., and Wada K. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum. Mol. Genet. 17 (2008) 1482-1496
11. Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., and Iwai K. A ubiquitin ligase complex assembles linear polyubiquitin chains. Embo J. 25 (2006) 4877-4887
12. Kirkpatrick D., Denison C., and Gygi S. Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat. Cell Biol. 7 (2005) 750-757
13. Kurihara L.J., Kikuchi T., Wada K., and Tilghman S.M. Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia. Hum. Mol. Genet. 10 (2001) 1963-1970
14. Kurihara L.J., Semenova E., Levorse J.M., and Tilghman S.M. Expression and functional analysis of Uch-L3 during mouse development. Mol. Cell Biol. 20 (2000) 2498-2504
15. Kwon J., Wang Y.L., Setsuie R., Sekiguchi S., Sakurai M., Sato Y., Lee W.W., Ishii Y., Kyuwa S., Noda M., Wada K., and Yoshikawa Y. Developmental regulation of ubiquitin C-terminal hydrolase isozyme expression during spermatogenesis in mice. Biol. Reprod. 71 (2004) 515-521
16. Larsen C.N., Krantz B.A., and Wilkinson K.D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37 (1998) 3358-3368
17. Larsen C.N., Price J.S., and Wilkinson K.D. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 35 (1996) 6735-6744
18. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., and Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature 395 (1998) 451-452
19. Liu Y., Fallon L., Lashuel H.A., Liu Z., and Lansbury Jr. P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111 (2002) 209-218
20. Manago Y., Kanahori Y., Shimada A., Sato A., Amano T., Sato-Sano Y., Setsuie R., Sakurai M., Aoki S., Wang Y.L., Osaka H., Wada K., and Noda M. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1. J. Neurochem. 92 (2005) 1061-1072
21. Misaghi S., Galardy P.J., Meester W.J., Ovaa H., Ploegh H.L., and Gaudet R. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate. J. Biol. Chem. 280 (2005) 1512-1520
22. Mukhopadhyay D., and Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315 (2007) 201-205
23. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., and Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005) 773-786
24. Nishikawa K., Li H., Kawamura R., Osaka H., Wang Y.L., Hara Y., Hirokawa T., Manago Y., Amano T., Noda M., Aoki S., and Wada K. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304 (2003) 176-183
25. Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., and Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296 (2002) 1132-1136
26. Osaka H., Wang Y.L., Takada K., Takizawa S., Setsuie R., Li H., Sato Y., Nishikawa K., Sun Y.J., Sakurai M., Harada T., Hara Y., Kimura I., Chiba S., Namikawa K., Kiyama H., Noda M., Aoki S., and Wada K. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12 (2003) 1945-1958
27. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006) 780-786
28. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., and Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23 (1999) 47-51
29. Sakurai M., Ayukawa K., Setsuie R., Nishikawa K., Hara Y., Ohashi H., Nishimoto M., Abe T., Kudo Y., Sekiguchi M., Sato Y., Aoki S., Noda M., and Wada K. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J. Cell Sci. 119 (2006) 162-171
30. Sakurai M., Sekiguchi M., Zushida K., Yamada K., Nagamine S., Kabuta T., and Wada K. Reduction in memory in passive avoidance learning, exploratory behaviour and synaptic plasticity in mice with a spontaneous deletion in the ubiquitin C-terminal hydrolase L1 gene. Eur. J. Neurosci. 27 (2008) 691-701
31. Sano Y., Furuta A., Setsuie R., Kikuchi H., Wang Y.L., Sakurai M., Kwon J., Noda M., and Wada K. Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice. Am. J. Pathol. 169 (2006) 132-141
32. Semenova E., Wang X., Jablonski M.M., Levorse J., and Tilghman S.M. An engineered 800 kilobase deletion of Uchl3 and Lmo7 on mouse chromosome 14 causes defects in viability, postnatal growth and degeneration of muscle and retina. Hum. Mol. Genet. 12 (2003) 1301-1312
33. Setsuie R., and Wada K. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51 (2007) 105-111
34. Setsuie R., Wang Y.L., Mochizuki H., Osaka H., Hayakawa H., Ichihara N., Li H., Furuta A., Sano Y., Sun Y.J., Kwon J., Kabuta T., Yoshimi K., Aoki S., Mizuno Y., Noda M., and Wada K. Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50 (2007) 119-129
35. Todaro G.J., and Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell. Biol. 17 (1963) 299-313
36. van Nocker S., and Vierstra R.D. Multiubiquitin chains linked through lysine 48 are abundant in vivo and are competent intermediates in the ubiquitin proteolytic pathway. J. Biol. Chem. 268 (1993) 24766-24773
37. Wada H., Kito K., Caskey L.S., Yeh E.T., and Kamitani T. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem. Biophys. Res. Commun. 251 (1998) 688-692
38. Walters B., Campbell S., Chen P., Taylor A., Schroeder D., Dobrunz L., Artavanistsakonas K., Ploegh H., Wilson J., and Cox G. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity. Mol. Cell. Neurosci. (2008) 45
39. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. Faseb J. 11 (1997) 1245-1256
40. Wilkinson K.D., Laleli-Sahin E., Urbauer J., Larsen C.N., Shih G.H., Haas A.L., Walsh S.T., and Wand A.J. The binding site for UCH-L3 on ubiquitin: mutagenesis and NMR studies on the complex between ubiquitin and UCH-L3. J. Mol. Biol. 291 (1999) 1067-1077
41. Wilkinson K.D., Lee K.M., Deshpande S., Duerksen-Hughes P., Boss J.M., and Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246 (1989) 670-673
42. Wood M., Kaplan M., Brensinger C., Guo W., and Abel T. Ubiquitin C-terminal hydrolase L3 (Uchl3) is involved in working memory. Hippocampus 15 (2005) 610-621
43. Yin L., Krantz B., Russell N.S., Deshpande S., and Wilkinson K.D. Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation. Biochemistry 39 (2000) 10001-10010